The global market for cardiac drug stents had a size of USD 9.93 billion in 2022, and it is projected to achieve a revenue Compound Annual Growth Rate (CAGR) of 5.9% throughout the forecast period. Key drivers for the growth in market revenue include the increasing incidence of cardiovascular diseases, a shift towards less invasive therapeutic procedures, faster evaluation and approval...